Eli Lilly Covid - Search News

Eli Lilly (LLY) Stock Eyes Price Breakout as Q4 Results Loom

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 earnings figures before

Benzinga.com · 1h

What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?

Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024.

Investopedia on MSN · 16h

What Analysts Think of Eli Lilly Stock Ahead of Earnings

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Business Insider · 5h

Eli Lilly & Co (LLY) Gets a Buy from Jefferies

Jefferies analyst Akash Tewari maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on February 3 and set a price target of

Ad Age · 8h

How Eli Lilly is approaching GLP-1 marketing and what’s next

Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, including with its GLP-1 medications.

Investing.com on MSN · 1d

Eli Lilly's SWOT analysis: stock poised for growth amid challenges

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been making waves in the biopharmaceutical industry with its strong portfolio of drugs,

7hon MSN

Merck Is Suffering From a Classic Pharma Problem

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products. Consider Pfizer. The company’s inability to accurately project demand for its Covid-19 ...

FiercePharma1d

Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.” | The company benefited from higher-than-expected sales of ...

Seeking Alpha5d

LLY Eli Lilly and Company

Eli Lilly and Company discovers ... severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis ...

btimesonline1d

Pfizer Beats Q4 Earnings Estimates as COVID Sales and Cost Cuts Drive Growth

Pfizer Inc. (PFE) exceeded Wall Street expectations in its fourth-quarter and full-year 2024 earnings report, bolstered by ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results